Skip to content

Clinical trials

Completed Observational Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Status: Completed Clear all

209 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20032
20042
20055
200610
20075
20089
20097
201011
201112
20128
20137
201410
201513
201612
201714
20189
201911
20207
202114
202214
202312
20248

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed209

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene20
Takeda8
Janssen Korea, Ltd., Korea6
Bristol-Myers Squibb5
Pfizer5
iOMEDICO AG5
SWOG Cancer Research Network4
Centre Hospitalier Universitaire de Saint Etienne3
Fondazione EMN Italy Onlus3
Genzyme, a Sanofi Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma209
Lymphoma24
Neoplasms, Plasma Cell24
Lymphoma, Non-Hodgkin20
Leukemia, Lymphocytic, Chronic, B-Cell17
Leukemia16
Myelodysplastic Syndromes16
Hodgkin Disease14
Myeloproliferative Disorders14
Recurrence13

Trials

Showing 1 to 25 of 209. Each trial links to its page on Pharma Observatory.

109 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.